Translate this site using Google Translate in 简体中文, 繁體中文, فارسی, தமிழ், Español, Português, Français, Русский, Italiano, 한국어, اردو, and other languages.
Vaxneuvance® (PNEU-C-15), Prevnar™20 (PNEU-C-20) and Capvaxive® (Pneu-C-21)
Pneumococcal disease is caused by different strains of the bacteria Streptococcus pneumoniae (S. pneumoniae). It is spread through respiratory droplets from direct or indirect contact. Anyone can get a pneumococcal infection. Infections can lead to meningitis, serious blood infections (sepsis), pneumonia (lung infection), ear infections or sinus infections.
The disease can be serious in children under two years of age, people with certain medical conditions or other risk factors, and adults 65 years of age or older. Vaccination is the best protection.
Pneumococcal vaccines are recommended for routine immunization of infants, children and adults, as well as those who are at higher risk of getting very sick from an infection. Pneumococcal vaccines (Vaxneuvance® (PNEU-C-15), Prevnar™20 (PNEU-C-20) and Capvaxive® (Pneu-C-21) are approved by Health Canada and are safe and effective. They are used not only in Canada, but around the world.
The vaccines work by helping the body to make its own antibodies. The vaccines provide 70 to 95 per cent protection
The vaccine is generally well tolerated. Vaccine side effects are usually mild and last one to two days. Common reactions include soreness, redness and/or swelling where the vaccine was given, fever, drowsiness, loss of appetite, headache, muscle or joint ache, chills and/or fussiness (irritability) – infants only.
In rare cases, serious reactions such as trouble breathing, hives, rash, swelling in the throat and face, a fast heartbeat, dizziness or weakness can occur. These reactions are usually temporary and can be treated. Please stay at the clinic for 15 minutes after vaccination so staff can monitor for any reactions.
Pneumococcal vaccines are free (publicly funded) for the following groups.
| Vaccine | Eligibility |
|---|---|
| Vaxneuvance® (PNEU-C-15) | Routine infant immunization at 2, 4, and 12 months of age. |
| Prevnar™20 (PNEU-C-20) |
|
| Capvaxive® (Pneu-C-21) | Individuals 65 years of age and older who have not received a publicly funded pneumococcal vaccine. |
* No additional doses are needed for children who have already received at least one dose of PNEU-C-20.
These vaccines can be given at the same time as other vaccines including influenza and COVID-19.
They are only given to individuals who have not previously had a pneumococcal vaccine series. Talk to your health care provider to determine your vaccine eligibility.
If you are not eligible for the free vaccine, speak to your health care provider to see if it is recommended for you. It may be available for private purchase or check with your private health coverage if it is covered for you.